Albumin solutions have been widely employed in the intensive care to set for correction of hypoalbuminemia and intravascular volume expansion in critical patients.[22] S-Alb is a marker of disease severity of MG, nevertheless, it was uncertain whether treating with hypoalbuminemia will improve the outcome of the disease. The gene discussed is ALB; the disease is Hypoalbuminemia.